0001209191-23-003606.txt : 20230117 0001209191-23-003606.hdr.sgml : 20230117 20230117193946 ACCESSION NUMBER: 0001209191-23-003606 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230115 FILED AS OF DATE: 20230117 DATE AS OF CHANGE: 20230117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mancini Marianna CENTRAL INDEX KEY: 0001838112 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 23532619 MAIL ADDRESS: STREET 1: C/O VIKING THERAPEUTICS, INC. STREET 2: 12340 EL CAMINO REAL, STE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-15 0 0001607678 Viking Therapeutics, Inc. VKTX 0001838112 Mancini Marianna C/O VIKING THERAPEUTICS, INC. 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 0 1 0 0 Chief Operating Officer Common Stock, par value $0.00001 per share 2023-01-15 4 F 0 1079 8.95 D 317273 D These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units. /s/ Michael Morneau, as Attorney-in-Fact 2023-01-17